NASDAQ:THAR - Nasdaq - US4327053090 - Common Stock - Currency: USD
Tharimmune, Inc. (NASDAQ:THAR) shares initially traded higher on Monday, but have since reversed after the company presented clinical data at the 75th American Association for the Study of Liver Disease (AASLD) meeting. Here's what you need to know.
Tharimmune just reported results for the second quarter of 2024.
Tharimmune stock is on the move Friday as investors prepare for a reverse split of THAR shares after markets close today.
Verastem stock is down on Friday with heavy trading of VSTM shares alongside its latest pancreatic cancer clinical trial safety data.
Sensei Biotherapeutics stock is falling on Friday as SNSE investors are unimpressed by its latest clinical trial data.
We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news!